Hormones
Research reports on hormones from R. Orvieto and colleagues provide new insights
Published in Pharma Investments, Ventures and Law Weekly, January 13th, 2008
According to a study from Israel, "The aim of the study was to investigate whether controlled ovarian hyperstimulation (COH) using multi-dose gonadotropin-releasing hormone (GnPH) antagonist results in a lesser degree of systemic inflammation than the GnRH-agonist long protocol. Prospective, observational study. Blood was drawn three times during the COH cycle from patients undergoing the long GnRH-agonist protocol (agonist group) (n = 12) or the multi-dose GnRH-antagonist protocol (antagonist group) (n = 15): the day on which adequate suppression was obtained (agonist group), or day 2 or 3 of the menstrual cycle and before gonadotropin treatment (antagonist group) (Day-0); the day of or...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- 012 Smile.Communications Ltd
012 Smile.Communications to Deploy Extensive WiFi Internet Access System for Sheba Medical Center - 90octane
90octane Selected as Interactive Marketing Agency for Symetix Lead Generation Program - AARP
AARP Calls New EEOC Policy 'A Civil Rights and Economic Fiasco' - Abscess Therapy
Researchers at Women's and Children's Hospital have published new data on abscess therapy - Access Pharmaceuticals, Inc.
Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO - Acid Reflux Disease
Reports from University of Louvain add new data to research in acid reflux disease - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
